Childhood-onset hypophosphatasia

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Childhood-onset hypophosphatasia.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Childhood-onset hypophosphatasia.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Strensiq

(ASFOTASE ALFA)Orphan drugstandard

Alexion Pharmaceuticals, Inc.

Tissue-nonspecific Alkaline Phosphatase [EPC]

12.1 Mechanism of Action HPP is caused by a deficiency in TNSALP enzyme activity, which leads to elevations in several TNSALP substrates, including in...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Childhood-onset hypophosphatasia.
Search all trials →
Search clinical trials for Childhood-onset hypophosphatasia

Recent News & Research

No recent news articles indexed yet for Childhood-onset hypophosphatasia.
Search PubMed for Childhood-onset hypophosphatasia

Browse all Childhood-onset hypophosphatasia news →

Specialist Network

No specialists currently listed for Childhood-onset hypophosphatasia.

View all Childhood-onset hypophosphatasia specialists →

Quick Actions